NEOG - Neogen Corporation Latest News | Finranks

NEOG - Neogen Corporation Latest News | Finranks

Neogen Announces Sale of Genomics Business to Zoetis

Neogen Announces Sale of Genomics Business to Zoetis

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. (“Zoetis”), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the company's portfolio review strategy to simplify the business and focus on core s.

Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves

Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves

Neogen Corporation's sizeable $11 billion food-and-animal safety TAM still has secular tailwinds with regulation, traceability, and disease-prevention trends. Management believes this market has an overall projected 6%–7% CAGR through 2030. In that context, NEOG's Petrifilm anchors future recurring consumables and end-to-end testing ecosystem.

Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination

Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination

Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Why Neogen Stock Blasted More Than 31% Higher Today

Why Neogen Stock Blasted More Than 31% Higher Today

The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.

Videos

No Data

There is no data to display